Home > Healthcare & Medical Devices > Neurostimulation Devices Market

Neurostimulation Devices Market Size By Product (Deep Brain Stimulator, Gastric Electric Stimulator, Spinal Cord Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Transcutaneous Electrical Nerve Stimulation [TENS]), By Application (Pain Management, Epilepsy, Essential Tremor, Urinary and Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2021 – 2027

  • Report ID: GMI436
  • Published Date: Jan 2022
  • Report Format: PDF

Industry trends

Neurostimulation Devices Market size exceeded USD 7 billion in 2020 and is anticipated to grow at a CAGR of over 10.2% between 2021 and 2027. Technological improvements and rising demand for advanced neurostimulation devices to improve patient outcomes will positively impact the market growth.

Neurostimulation Devices Market Overview

Get more details on this report - Request Free Sample PDF

Continuously rising prevalence of numerous health aliments such as epilepsy, depression, Parkinson's disease, migraine, and others favour the demand for different neurostimulation devices. In addition, favourable regulatory scenario for medical modalities for superior patient care as well as management will foster the market expansion.

COVID-19 pandemic minimally impacted the neurostimulation devices market during the initial breakdown due to hindrance in supply chain and scarcity of workforce. Restrictions imposed by the government has slowed down the supply chain and distribution network of various companies to some extent. However, the supply resumed in the second half of 2020. COVID-19 pandemic may pose a risk to several small companies in the underdeveloped and developing regions. Also, a decline in the treatment for non-COVID-19 emergency procedures has also negatively impacted the overall demand for neurostimulation devices.

Technological advancements in neurostimulation devices will propel the market progression

Rising advancements and developments in neurostimulation devices is expected to provide relief to an unprecedented number of patients affected by serious neurologic and psychiatric disorders. Availability of implantable neurostimulation devices that target specific cranial, spinal, and peripheral nerve structures to regulate neuronal activity and further provide therapeutic effects for a variety of neurological disorders is predicted to favour the industry growth.

Moreover, various market participants operating in the neurostimulation devices business are focusing on developing technologically advanced devices to ease the pain of patients. However, complications associated with neurostimulation devices may restrict the industry expansion to a certain extent during the forecast timeline.

Increasing demand for deep brain stimulators will favor the market demand

The deep brain stimulator (DBS) segment in the neurostimulation devices market is estimated to witness around 12.5% growth rate through 2027 owing to the rising research and development activities in order to develop improved deep brain stimulators. Also, new product launches and innovations in deep brain stimulators will accelerate the industry progression.

DBS facilitate change in brain stimulator injection in accordance with patient’s response to disease progression and medication with an aim to exclude the need for surgery. In addition, various benefits of deep brain stimulator such as no permanent damage unlike other surgical options will drive the overall market value.

Growing prevalence of Parkinson’s disease will influence the market revenue

Neurostimulation Devices Market Size

Get more details on this report - Request Free Sample PDF

The neurostimulation devices market for Parkinson’s disease segment accounted for 7.3% of the market share in 2020 led by the increasing prevalence of the disease worldwide. Various symposiums and awareness programs regarding the disease will create awareness among the general population base.

Rising prevalence of neurological disorders in North America region to stimulate the industry value

North America Neurostimulation Devices Market

Get more details on this report - Request Free Sample PDF

North America neurostimulation devices market size was over USD 3.8 billion in 2020 due to the increasing prevalence of neurological diseases in the region. For instance, according to the Centers for Disease Control (CDC) report, in the U.S. the burden of Alzheimer’s disease and related dementias (ADRD) will double by 2060. The rise in number of ADRD can be attributed to rising geriatric population base, and unhealthy lifestyle. Additionally, increasing R&D and adoption of minimally invasive techniques along with development of technologically advanced neurostimulation devices are factors boosting the regional growth.

Strategic initiatives undertaken by companies have helped them to evolve as prominent market players

Some of the prominent leaders operating in the neurostimulation devices market include Abbott, Boston Scientific Corporation, IntraPace, Laborie, LivaNova, Medtronic, Neuronetics, SPR Therapeutics, Cyberonics, ElectroCore Inc., Aleva Neurotherapeutics SA, Synapse Biomedical Inc., MicroTransponder, RS Medical and BioControl Medical. The leading market participants are undertaking numerous inorganic and organic growth strategies to gain higher revenue share.

The neurostimulation devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027, for the following segments:

Market, By Product, 2016 -2027 (USD Million)

  • Deep Brain Stimulator
  • Gastric Electric Stimulator
  • Spinal Cord Stimulator
  • Sacral Nerve Stimulator
  • Vagus Nerve Stimulator
  • Transcutaneous Electrical Nerve Stimulation (TENS)
  • Others

Market, By Application, 2016 -2027 (USD Million)

  • Pain Management
  • Epilepsy
  • Essential Tremor
  • Urinary and Fecal Incontinence
  • Depression
  • Dystonia
  • Gastroparesis
  • Parkinson's Disease
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa
    • Saudi Arabia


Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

The market size of neurostimulation devices crossed USD 7 billion in 2020 and will strike a growth rate of more than 10.2% through 2027 owing to the rising adoption of advanced neurostimulation devices and higher technological improvements.

Neurostimulator is a surgically placed device that is used in the treatment of a wide range of different diseases, including Parkinson's disease, epilepsy, and migraine.

The deep brain stimulator (DBS) product segment is poised to depict a 12.5% growth rate through 2027 due to the rising R&D activities and the increasing number of new product launches and innovations.

The Parkinson’s disease application segment held close to 7.3% of the market share in 2020, impelled by the higher disease burden along with the presence of various symposiums and awareness programs.

North America market size was valued at over USD 3.8 billion in 2020 and will substantially grow with the rising threat of neurological diseases in the region.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2020
  • Companies covered: 17
  • Tables & Figures: 139
  • Countries covered: 14
  • Pages: 110

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount